Check-Cap (MBAI) Total Non-Current Liabilities (2013 - 2025)
Check-Cap (MBAI) posted Total Non-Current Liabilities of $43626.0 for Q4 2025, up 172.66% sequentially from $16000.0 in Q2 2025, and up 172.66% YoY from $16000.0 in Q4 2024.
Check-Cap (MBAI) Total Non-Current Liabilities (2013 - 2025) Analysis & Trends
Check-Cap has reported Total Non-Current Liabilities for 13 years, with the latest figure at $43626.0 in Q4 2025.
- Quarterly Total Non-Current Liabilities rose 172.66% year-over-year to $43626.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $43626.0 (up 172.66% YoY) and the FY2025 annual result came in at $43626.0, up 172.66% from the prior year.
- Total Non-Current Liabilities rose to $43626.0 in Q4 2025 per MBAI's latest filing, from $16000.0 in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $1.1 million in Q1 2021 and troughed at $16000.0 in Q4 2024.
- A 5-year average of $664302.2 and a median of $782000.0 in 2022 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2021 and 2022: Total Non-Current Liabilities surged 236.91% in 2021, then decreased 22.71% in 2022.
- Over 5 years, Total Non-Current Liabilities stood at $927000.0 in 2021, then decreased by 22.22% to $721000.0 in 2022, then advanced by 0.42% to $724000.0 in 2023, then tumbled by 97.79% to $16000.0 in 2024, then jumped by 172.66% to $43626.0 in 2025.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $43626.0, $16000.0, and $16000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 715.49 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 542.10 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 9.19 Bn |
| 10 | Check-Cap | 5.89 Mn | -793.79 Mn | - | 43.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43.63 Mn |
| Jun 30, 2025 | 16,000.00 |
| Dec 31, 2024 | 16,000.00 |
| Mar 31, 2023 | 724,000.00 |
| Dec 31, 2022 | 721,000.00 |
| Sep 30, 2022 | 788,000.00 |
| Jun 30, 2022 | 776,000.00 |
| Mar 31, 2022 | 934,000.00 |
| Dec 31, 2021 | 927,000.00 |
| Sep 30, 2021 | 970,000.00 |
| Jun 30, 2021 | 1.00 Mn |
| Mar 31, 2021 | 1.05 Mn |
| Dec 31, 2020 | 279,000.00 |
| Sep 30, 2020 | 330,000.00 |
| Jun 30, 2020 | 298,000.00 |
| Mar 31, 2020 | 344,000.00 |
| Dec 31, 2019 | 393,000.00 |
| Sep 30, 2019 | 458,000.00 |
| Jun 30, 2019 | 424,000.00 |
| Mar 31, 2019 | 206,000.00 |